文献速递肝病

逆转代谢功能障碍相关脂肪性肝病促进儿童心血管结构健康:PROC研究

Reversing Metabolic Dysfunction-Associated Steatotic Liver Disease Promotes Healthy Pediatric Cardiovascular Structures: The PROC Study.
PubMed 文献 · Am J Gastroenterol · 2024-04-11

研究在北京随访1356名平均6.6岁儿童4.5年,评估MASLD与心血管结构(颈动脉内中膜厚度和左心室质量)的关联。随访期间59名儿童持续MASLD,109名新发MASLD,35名肝脏健康恢复正常。MASLD恢复正常儿童的颈动脉内中膜厚度和左心室质量平均发展显著低于持续MASLD儿童。

要点

  • MASLD恢复正常儿童颈动脉内中膜厚度平均发展0.161 mm,持续MASLD儿童为0.188 mm。
  • MASLD恢复正常儿童左心室质量平均发展4.5 g,持续MASLD儿童为12.4 g。
  • MASLD控制与儿童心血管结构发展改善相关。

核心结论

  • MASLD的控制与儿童心血管结构发展改善相关。

研究设计与样本

  • 研究随访了1356名平均年龄6.6岁的儿童,随访4.5年,地点为中国北京。
  • 在基线和随访时评估MASLD与心血管结构(颈动脉内中膜厚度和左心室质量)结局的关联。

主要发现

  • 随访期间,59名儿童持续MASLD,109名新发MASLD(进展),35名肝脏健康恢复正常。
  • MASLD恢复正常儿童颈动脉内中膜厚度平均发展0.161 mm,持续MASLD儿童为0.188 mm,前者显著较低。
  • MASLD恢复正常儿童左心室质量平均发展4.5 g,持续MASLD儿童为12.4 g,前者显著较低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: We investigated the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on cardiovascular structure development in children. METHODS: We followed 1,356 children with the mean age of 6.6 years for 4.5 years in Beijing, China. We assessed the association of MASLD with cardiovascular structure (carotid intima-media thickness and left ventricular mass) outcomes at baseline and follow-up. RESULTS: Over follow-up, 59 children had persistent MASLD, 109 had incident MASLD (progression), and 35 had normalization of liver health. Children with MASLD normalization showed a significantly lower mean development in carotid intima-media thickness (0.161 vs 0.188 mm) and left ventricular mass (4.5 vs 12.4 g) than children with persistent MASLD. DISCUSSION: The control of MASLD was associated with improved cardiovascular structure development.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Li M, Shu W, Zou Y, et al. Reversing Metabolic Dysfunction-Associated Steatotic Liver Disease Promotes Healthy Pediatric Cardiovascular Structures: The PROC Study. Am J Gastroenterol. 2024. PMID: 38775939. doi:10.14309/ajg.0000000000002804

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。